TREATMENT OF NEPHROSIS WITH CONCENTRATED HUMAN SERUM ALBUMIN. I. EFFECTS ON THE PROTEINS OF BODY FLUIDS

^{Department of Medicine, The Johns Hopkins University and Hospital, Baltimore}

Present address: Stanford University Hospitals, San Francisco 15, California.

This investigation was supported by a research grant from the Division of Research Grants and Fellowships of the National Institute of Health, U. S. Public Health Service.

The concentrated human serum albumin used in this study was made available in the largest part by the American Red Cross, and in smaller amounts for specific cases by the Sharp and Dohme Company and by the U. S. Navy.

Find articles by Luetscher, J. in: PubMed | Google Scholar

^{Department of Medicine, The Johns Hopkins University and Hospital, Baltimore}

Present address: Stanford University Hospitals, San Francisco 15, California.

This investigation was supported by a research grant from the Division of Research Grants and Fellowships of the National Institute of Health, U. S. Public Health Service.

The concentrated human serum albumin used in this study was made available in the largest part by the American Red Cross, and in smaller amounts for specific cases by the Sharp and Dohme Company and by the U. S. Navy.

Find articles by Hall, A. in: PubMed | Google Scholar

^{Department of Medicine, The Johns Hopkins University and Hospital, Baltimore}

Present address: Stanford University Hospitals, San Francisco 15, California.

This investigation was supported by a research grant from the Division of Research Grants and Fellowships of the National Institute of Health, U. S. Public Health Service.

The concentrated human serum albumin used in this study was made available in the largest part by the American Red Cross, and in smaller amounts for specific cases by the Sharp and Dohme Company and by the U. S. Navy.

Find articles by Kremer, V. in: PubMed | Google Scholar